DEXCOM INC Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2018 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Dexcom Inc quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2018 to Q3 2024.
  • Dexcom Inc Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $67.5M, a 8.04% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $67.5M -$5.9M -8.04% Sep 30, 2024 10-Q 2024-10-24
Q2 2024 $71.2M -$5.1M -6.68% Jun 30, 2024 10-Q 2024-07-25
Q1 2024 $68M -$10M -12.8% Mar 31, 2024 10-Q 2024-04-25
Q4 2023 $71.4M -$8.6M -10.8% Dec 31, 2023 10-Q 2024-10-24
Q3 2023 $73.4M +$300K +0.41% Sep 30, 2023 10-Q 2023-10-26
Q2 2023 $76.3M -$1.6M -2.05% Jun 30, 2023 10-Q 2023-07-27
Q1 2023 $78M -$4.3M -5.23% Mar 31, 2023 10-Q 2023-04-27
Q4 2022 $80M -$8.1M -9.19% Dec 31, 2022 10-K 2024-02-08
Q3 2022 $73.1M -$18.2M -19.9% Sep 30, 2022 10-Q 2022-10-27
Q2 2022 $77.9M -$16.9M -17.8% Jun 30, 2022 10-Q 2022-07-28
Q1 2022 $82.3M -$16.5M -16.7% Mar 31, 2022 10-Q 2022-04-28
Q4 2021 $88.1M -$5.2M -5.57% Dec 31, 2021 10-K 2023-02-09
Q3 2021 $91.3M -$3M -3.18% Sep 30, 2021 10-Q 2021-10-28
Q2 2021 $94.8M +$23.2M +32.4% Jun 30, 2021 10-Q 2021-07-29
Q1 2021 $98.8M +$25M +33.9% Mar 31, 2021 10-Q 2021-04-29
Q4 2020 $93.3M +$21.8M +30.5% Dec 31, 2020 10-K 2022-02-14
Q3 2020 $94.3M +$59.7M +173% Sep 30, 2020 10-Q 2020-10-27
Q2 2020 $71.6M +$35.8M +100% Jun 30, 2020 10-Q 2020-07-28
Q1 2020 $73.8M +$46.1M +166% Mar 31, 2020 10-Q 2020-04-28
Q4 2019 $71.5M +$71.5M Dec 31, 2019 10-K 2021-02-11
Q3 2019 $34.6M Sep 30, 2019 10-Q 2019-11-06
Q2 2019 $35.8M Jun 30, 2019 10-Q 2019-07-31
Q1 2019 $27.7M Mar 31, 2019 10-Q 2019-05-01
Q4 2018 $0 Dec 31, 2018 10-K 2020-02-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.